title: Psychotic symptoms in the course of sunitinib treatment for advanced renal cell cancer. Two cases.
authors.affiliation: Department of Psychiatry (961), Radboud University Nijmegen Medical Centre, P.O. Box 9100 HB, Nijmegen, The Netherlands. a.f.a.schellekens@psy.umcn.nl
authors.forename: Arnt F A
authors.initials: AF
authors.lastname: Schellekens
authors.forename: Sasja F
authors.initials: SF
authors.lastname: Mulder
authors.forename: Philip F P
authors.initials: PF
authors.lastname: van Eijndhoven
authors.forename: Tineke J
authors.initials: TJ
authors.lastname: Smilde
authors.forename: Carla M L
authors.initials: CM
authors.lastname: van Herpen
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007211:Indoles / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D009426:Netherlands; D011605:Psychoses, Substance-Induced / Q000209:etiology*; D011758:Pyrroles / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D000077210:Sunitinib; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D042461:Vascular Endothelial Growth Factor A; D000077210:Sunitinib